The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
The impact of hypoxia and its modification of the outcome of radiotherapy
Open accessAbstract
Since the initial observations made at the beginning of the last century, it has been established that solid tumors contain regions of low oxygenation (hypoxia). Tumor cells can survive in these hypoxic conditions and are a major factor in tumor radioresistance. This significance has resulted in hypoxia becoming the most cited biological topic in translational radiation oncology. Identifying hypoxic cells in human tumors has become paramount, and the ability to do this has been improved by the help of new imaging techniques and the use of predictive gene profiles. Substantial data confirm the presence of hypoxia in many types of human tumors, although with considerable heterogeneity among individual tumors. Various approaches have been investigated for eliminating the hypoxic population. These include increasing oxygen availability, directly radiosensitizing or killing the hypoxic cells, indirectly affecting them by targeting the tumor vascular supply, increasing the radiation dose to this resistant population, or by using radiation with a high linear energy transfer, for which hypoxia is believed to be less of an issue. Many of these approaches have undergone controlled clinical trials during the last 50 years, and the results have shown that hypoxic radiation resistance can indeed be overcome. Thus, ample data exists to support a high level of evidence for the benefit of hypoxic modification. However, such hypoxic modification still has no impact on general clinical practice. In this review we summarize the biological rationale, and the current activities and trials, related to identifying and overcoming hypoxia in modern radiotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting hypoxia in cancer therapy
Wilson, W. R., & Hay, M. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3064 · Cited by 3,172
The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy
Thomlinson, R. H., & Gray, L. H. (1955) · British Journal of Cancer · doi:10.1038/bjc.1955.55 · Cited by 2,219
Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy
Jain, R. K. (2001) · Nature Medicine · doi:10.1038/nm0901-987 · Cited by 2,184
Gray, L. H., Conger, A. D., Ebert, M., Hornsey, S., & Scott, O. C. A. (1953) · The British Journal of Radiology · doi:10.1259/0007-1285-26-312-638 · Cited by 2,158
Helmlinger, G., Yuan, F., Dellian, M., & Jain, R. K. (1997) · Nature Medicine · doi:10.1038/nm0297-177 · Cited by 1,628
Nordsmark, M., Bentzen, S. M., Rudat, V., Brizel, D., Lartigau, E., Stadler, P., Becker, A., Adam, M., Molls, M., Dunst, J., et al. (2005) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2005.06.038 · Cited by 953
Self-citationTowards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality
Ling, C. C., Humm, J., Larson, S., Amols, H., Fuks, Z., Leibel, S., & Koutcher, J. A. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00467-3 · Cited by 926
Imaging hypoxia to improve radiotherapy outcome
Horsman, M. R., Mortensen, L. S., Petersen, J. B., Busk, M., & Overgaard, J. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.171 · Cited by 614
Self-citationOvergaard, J., Sand Hansen, H., Overgaard, M., Bastholt, L., Berthelsen, A., Specht, L., Lindeløv, B., & Jørgensen, K. (1998) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(97)00220-x · Cited by 573
Self-citationEvidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation
Brown, J. M. (1979) · The British Journal of Radiology · doi:10.1259/0007-1285-52-620-650 · Cited by 526
Hyperthermia: a Potent Enhancer of Radiotherapy
Horsman, M. R., & Overgaard, J. (2007) · Clinical Oncology · doi:10.1016/j.clon.2007.03.015 · Cited by 463
Self-citationIntermittent blood flow in a murine tumor: radiobiological effects.
Chaplin, D. J., Olive, P. L., & Durand, R. E. (1987) · PubMed · Cited by 436
SR-4233: A new bioreductive agent with high selective toxicity for hypoxic mammalian cells
Zeman, E. M., Brown, J. M., Lemmon, M. J., Hirst, V. K., & Lee, W. W. (1986) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(86)90267-1 · Cited by 402
Kimura, H., Braun, R. D., Ong, E. T., Hsu, R., Secomb, T. W., Papahadjopoulos, D., Hong, K., & Dewhirst, M. W. (1996) · PubMed · Cited by 364
Adams, G. E., Flockhart, I. R., Smithen, C. E., Stratford, I. J., Wardman, P., & Watts, M. E. (2012) · Radiation Research · doi:10.1667/rrav14.1 · Cited by 347
Radiotherapy With Concurrent Carbogen and Nicotinamide in Bladder Carcinoma
Hoskin, P. J., Rojas, A. M., Bentzen, S. M., & Saunders, M. I. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.4950 · Cited by 332
Reprogramming Metabolism with Metformin Improves Tumor Oxygenation and Radiotherapy Response
Zannella, V. E., Dal Pra, A., Muaddi, H., McKee, T. D., Stapleton, S., Sykes, J., Glicksman, R., Chaib, S., Zamiara, P., Milosevic, M., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1787 · Cited by 314
Mortensen, L. S., Johansen, J., Kallehauge, J., Primdahl, H., Busk, M., Lassen, P., Alsner, J., Sørensen, B. S., Toustrup, K., Jakobsen, S., et al. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2012.09.015 · Cited by 308
Self-citationRadiation and High-Dose Metronidazole in Supratentorial Glioblastomas
Urtasun, R., Band, P., Chapman, J. D., Feldstein, M. L., Mielke, B., & Fryer, C. (1976) · New England Journal of Medicine · doi:10.1056/nejm197606172942503 · Cited by 306
Adams, G. E., Flockhart, I. R., Smithen, C. E., Stratford, I. J., Wardman, P., & Watts, M. E. (1976) · Radiation Research · doi:10.2307/3574491 · Cited by 297
Differentiation and Definition of Vascular-Targeted Therapies
Siemann, D. W., Bibby, M. C., Dark, G. G., Dicker, A. P., Eskens, F. A. L. M., Horsman, M. R., Marmé, D., & LoRusso, P. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.416.11.2 · Cited by 272
Self-citationAssociation of metformin use with cancer incidence and mortality: A meta-analysis
Zhang, P., Li, H., Tan, X., Chen, L., & Wang, S. (2013) · Cancer Epidemiology · doi:10.1016/j.canep.2012.12.009 · Cited by 270
Hyperthermic radiosensitization: mode of action and clinical relevance
KAMPINGA, H. H., & DIKOMEY, E. (2001) · International Journal of Radiation Biology · doi:10.1080/09553000010024687 · Cited by 259
ARCON: a novel biology-based approach in radiotherapy
Kaanders, J. H., Bussink, J., & van der Kogel, A. J. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00929-4 · Cited by 256
Janssens, G. O., Rademakers, S. E., Terhaard, C. H., Doornaert, P. A., Bijl, H. P., van den Ende, P., Chin, A., Marres, H. A., de Bree, R., van der Kogel, A. J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.9315 · Cited by 256
Toustrup, K., Sørensen, B. S., Nordsmark, M., Busk, M., Wiuf, C., Alsner, J., & Overgaard, J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1182 · Cited by 255
Self-citationHorsman, M. R., & Siemann, D. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2848 · Cited by 246
Self-citationClinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors.
Overgaard, J. (1994) · PubMed · Cited by 218
Self-citationOvergaard, J., Sand Hansen, H., Andersen, A. P., Hjelm-Hansen, M., Jørgensen, K., Sandberg, E., Berthelsen, A., Hammer, R., & Pedersen, M. (1989) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(89)90917-6 · Cited by 214
Self-citationReproducibility of Intratumor Distribution of 18F-Fluoromisonidazole in Head and Neck Cancer
Nehmeh, S. A., Lee, N. Y., Schröder, H., Squire, O., Zanzonico, P. B., Erdi, Y. E., Greco, C., Mageras, G., Pham, H. S., Larson, S. M., et al. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.08.036 · Cited by 210
Electron-affinic Sensitization: I. A Structural Basis for Chemical Radiosensitizers in Bacteria
Adams, G. E., & Cooke, M. S. (1969) · International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine · doi:10.1080/09553006914550741 · Cited by 207
Molecular and Cellular Pharmacology of the Hypoxia-Activated Prodrug TH-302
Meng, F., Evans, J. W., Bhupathi, D., Banica, M., Lan, L., Lorente, G., Duan, J.-X., Cai, X., Mowday, A. M., Guise, C. P., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0634 · Cited by 203
Lee, D.-J., Cosmatos, D., Marcial, V. A., Fu, K. K., Rotman, M., Cooper, J. S., Ortiz, H. G., Beitler, J. J., Abrams, R. A., Curran, W. J., et al. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)00150-w · Cited by 179
Bioreductive Drugs: from Concept to Clinic
McKeown, S. R., Cowen, R. L., & Williams, K. J. (2007) · Clinical Oncology · doi:10.1016/j.clon.2007.03.006 · Cited by 174
Adams, G. E., Asquith, J. C., Dewey, D. L., Foster, J. L., Michael, B. D., & Willson, R. L. (1971) · International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine · doi:10.1080/09553007114550751 · Cited by 173
Span, P. N., & Bussink, J. (2015) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2014.10.002 · Cited by 163
Sensitization of Hypoxic Tumour Cells—Clinical Experience
Overgaard, J. (1989) · International Journal of Radiation Biology · doi:10.1080/09553008914552081 · Cited by 163
Self-citationResponse of cells to hyperthermia under acute and chronic hypoxic conditions.
Gerweck, L. E., Nygaard, T. G., & Burlett, M. (1979) · PubMed · Cited by 158
Modelling of the oxygen enhancement ratio for ion beam radiation therapy
Wenzl, T., & Wilkens, J. J. (2011) · Physics in Medicine and Biology · doi:10.1088/0031-9155/56/11/006 · Cited by 157
Okamoto, S., Shiga, T., Yasuda, K., Ito, Y. M., Magota, K., Kasai, K., Kuge, Y., Shirato, H., & Tamaki, N. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.109330 · Cited by 157
The Influence of Hypoxia and Acidity on the Hyperthermic Response of Malignant CellsIn Vitro
Overgaard, J., & BICHEL, P. (1977) · Radiology · doi:10.1148/123.2.511 · Cited by 152
Self-citationHorsman, M. R. (1995) · Acta Oncologica · doi:10.3109/02841869509094031 · Cited by 135
Self-citationBarendsen, G. W. (1968) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · Cited by 128
Siemann, D. W., Hill, R. P., & Bush, R. S. (1977) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(77)90188-2 · Cited by 127
Vascular targeted therapies in oncology
Siemann, D. W., & Horsman, M. R. (2008) · Cell and Tissue Research · doi:10.1007/s00441-008-0646-0 · Cited by 121
Self-citationHorsman, M. R., Chaplin, D. J., & Overgaard, J. (1990) · PubMed · Cited by 120
Self-citationAcute Versus Chronic Hypoxia: Why a Simplified Classification is Simply Not Enough
Bayer, C., Shi, K., Astner, S. T., Maftei, C.-A., & Vaupel, P. W. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.02.049 · Cited by 115
Use of a perfluorochemical emulsion to improve oxygenation in a solid tumor
Rockwell, S. (1985) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(85)90367-0 · Cited by 110
Measurement of tumor oxygenation
Horsman, M. R. (1998) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00332-0 · Cited by 97
Self-citationHoff, C. M. (2012) · Acta Oncologica · doi:10.3109/0284186x.2011.653438 · Cited by 94
Carbogen breathing during radiation therapy The radiation therapy oncology group study
Rubin, P., Hanley, J. A., Keys, H. M., Marcial, V. A., & Brady, L. W. (1979) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(79)90946-5 · Cited by 90
Eschwège, F., Sancho-Garnier, H., Chassagne, D., Brisgand, D., Guerra, M., Malaise, E. P., Bey, P., Busutti, L., Cionini, L., Nguyen, T. D., et al. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00327-1 · Cited by 81
The Effect of Oxygen on the Response of Spontaneous Tumours in Mice to Radiotherapy
Du Sault, L. A. (1963) · The British Journal of Radiology · doi:10.1259/0007-1285-36-430-749 · Cited by 64
Chaplin, D., Horsman, M. R., & Siemann, D. W. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.326 · Cited by 64
Self-citationTargeting tumor blood vessels: an adjuvant strategy for radiation therapy
Siemann, D. W., Warrington, K. H., & Horsman, M. R. (2000) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(00)00243-7 · Cited by 62
Self-citationDische, S., Chassagne, D., Hope-Stone, H. F., Dawes, P. J. D., Roberts, J. T., Yosef, H., Bey, P., Horiot, J. C., Jacobson, A., Frankendal, B., et al. (1993) · Radiotherapy and Oncology · doi:10.1016/0167-8140(93)90089-q · Cited by 58
Busk, M., Mortensen, L. S., Nordsmark, M., Overgaard, J., Jakobsen, S., Hansen, K., Theil, J., Kallehauge, J. F., D’Andrea, F. P., Steiniche, T., et al. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2258-x · Cited by 53
Self-citationKarasawa, K., Sunamura, M., Okamoto, A., Nemoto, K., Matsuno, S., Nishimura, Y., & Shibamoto, Y. (2008) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2008.02.007 · Cited by 52
Dobrowsky, W., Huigol, N., Jayatilake, R., Kizilbash, N.-I.-A., Okkan, S., Kagiya, V. T., & Tatsuzaki, H. (2006) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2006.11.007 · Cited by 47
Introduction: Radiosensitization by hyperthermia
Roti, J. L. R. (2004) · International Journal of Hyperthermia · doi:10.1080/0265673032000173898 · Cited by 46
Rockwell, S. (1986) · International Journal of Cancer · doi:10.1002/ijc.2910380213 · Cited by 43
Tumor radiosensitization through reductions in hemoglobin affinity
Siemann, D. W., & Macler, L. M. (1986) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(86)90157-4 · Cited by 43
Clinical Trial with Atmospheric Oxygen Breathing during Radiotherapy of Cancer of the Cervix
Bergsjø, P., & Kolstad, P. (1968) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365516809168212 · Cited by 38
Mendenhall, W. M., Morris, C. G., Amdur, R. J., Mendenhall, N. P., & Siemann, D. W. (2005) · Cancer · doi:10.1002/cncr.21146 · Cited by 34
The oxygen dependence of the reduction of nitroimidazoles in a radiolytic model system
Rauth, A. M., MCCLELLAND, R. A., Michaels, H. B., & Battistella, R. (1984) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(84)90341-9 · Cited by 33
Iversen, A. B. B., Busk, M., & Horsman, M. R. (2013) · Acta Oncologica · doi:10.3109/0284186x.2013.825050 · Cited by 32
Self-citationThe Oxygen Effect in Radiotherapy � Historical Review
Churchill‐Davidson, I. (2015) · Frontiers of radiation therapy and oncology · doi:10.1159/000386946 · Cited by 27
In vitro hypoxic cytotoxicity of nitroimidazoles: Uptake and cell cycle phase specificity
Sutherland, R. M., Keng, P., Conroy, P. J., McDermott, D., Bareham, B. J., & Passalacqua, W. (1982) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(82)90726-x · Cited by 22
Cited by
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
Kamoun, A., de Reyniès, A., Allory, Y., Sjödahl, G., Robertson, A. G., Seiler, R., Hoadley, K. A., Groeneveld, C. S., Al-Ahmadie, H., Choi, W., et al. (2020) · European Urology · doi:10.1016/j.eururo.2019.09.006 · Cited by 1,359
Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy
Henke, E., Nandigama, R., & Ergün, S. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00160 · Cited by 1,142
Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer
Wu, F., Yang, J., Liu, J., Wang, Y., Mu, J., Zeng, Q., Deng, S., & Zhou, H. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00641-0 · Cited by 773
Wang, H., Mu, X., He, H., & Zhang, X.-D. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.11.003 · Cited by 572
The linear quadratic model: usage, interpretation and challenges
McMahon, S. J. (2018) · Physics in Medicine & Biology · doi:10.1088/1361-6560/aaf26a · Cited by 440
Metadata
- Authors
- Horsman, M. R., & Overgaard, J.
- Venue
- Journal of Radiation Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-03-16
- Volume
- 57
- Issue
- S1
- Pages
- i90-i98
- ISSN
- 0449-3060 (ISSN-L)
- 1349-9157
- OpenAlex
- W2303515996
- Cited by
- 311
- References
- 68
- FWCI
- 9.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.